The word 'standardisation' can imply two concepts: either 'to achieve a uniform standard of practice', or 'to compare with a standard of known or defined properties'. Both concepts can be applied to the standardisation of enzyme activity measurements.
The idea of a uniform standard of practice has motivated the many national and international attempts during the last 15 years to formulate recommended or standard enzyme assay methods. These efforts have met with considerable success, in reducing the number of unsatisfactory methods in routine use, and in improving the comparability of enzyme assay results between laboratories. The dissemination of recommended methods has been greatly aided bythe availabilityof prepackaged reagents which allow the recommended reaction conditions to be readily reproduced. However, there is a danger that the original specifications may become relaxed, in the interests of ease of manufacture, cost, and the convenience of the user. This danger becomes greater as the complexity of the recommended methods increases, and is particularly evident in attempts to translate into routine practice the 'state of the art' recommendations of the IFCC Expert Panel on Enzymes, with their emphasis on appropriate blanks and controls, reagent purity and instrumental performance. Though some of these requirements (e.g. those relating to reagent purity) can be met by manufacturers who offer prepackaged reagents 'optimised according to IFCC, others, such as the use of the specified controls and blanks and validation of the measuringinstruments, remain the responsibility of the user. The user must, therefore, decide whether his own resources of instrumentation and time can match the high standards that have, by implication, been applied to the selec-Correspondence: Professor Donald Moss, Department of Clinical Pathology. Royal Post-Graduate Medical School, Ducanc Road, London WI2, UK. tion and preparation of the reagents. It should be noted that merely to 'optimise'-Le. to select reagent concentrations--according to IFCC protocols without also adopting the associated procedural and instrumental specifications is likely to offer few if any discemible improvements in performance compared with the robust routine methods recommended by national enzyme committees.
In spite of its successes so far, the concept of standardised, widely-adopted, enzyme assay methodology faces two major challenges. The first of these is the need to respond to new knowledge of the nature and properties of enzymes. Growing knowledge means that older recommended methods are overtaken by newer recommendations which appear to offer advantages, although these may be theoretical rather than obvious in practice. As a result, numerous recommendations are current which differ to greater or lesser extents, and which display varying degrees of traceability to intemational recommendations, such as those of IFCC. A recent initiative has been taken in Europe to alleviate this problem by attempting to define a family of methods, based on national recommendations and therefore differing in minor details, but which can be expected to give numerically similar results when operated at the same temperature: in other words, to emphasise similarities between recommended methods rather than differences. This idea arose out of an informal gathering of European clinical enzymologists, but it will probably be carried forward by the newly-formed enzyme methods subcommittee of ECCLS, which will attempt to base widely-acceptable routine methods on the more recent national and IFCC recommendations. Any new recommendations are expected to involve what has been called 'intelligent corruption' of IFCC methods: relaxation of those requirements that are essential for the most accurate and unbiased assays, but which are of negligible influence in the context of daily clinical analysis. Such relaxations will be based on an informed assessment of the importance of the relevant sources of error and the magnitude oftheeffects of proposed changes, and not directed merely by procedural convenience.
. The hopes for the success of the 'European methods' approach rest on the fact that several current national recommendations differ in details that are probably insignificant in functional terms. Thus, it is expected that national societies and their enzyme committees will cease to bring forward their own recommendations, and will be prepared to endorse the changes-probably small in most casesnecessary for the adoption of the 'European' methods. That a willingness to do so already exists can be inferred from the fact that at least eight national committees have endorsed the 'European' N-acetylcysteine-activated method for creatine kinase (though without agreeing on the assay temperature) and this method itself seems likely to be endorsed by IFCC. External quality assessments indicate that these recommendations with respect to creatine kinase are indeed becoming widely and rapidly adopted in routine analysis. However, the translation of recommendation into practice is not always so rapid, as is seen in the question of whether aminotransferase methods should measure only preformed holoenzyme (i.e. without addition of pyridoxal-S'-phosphate) or, by adding this cofactor, all potentially active enzyme. The theoretical arguments in favour of this addition are incontrovertible; the anticipated practical advantages of improved reproducibility of assays or clinical discrimination are less apparent. Therefore, in spite of the almost universal consensus of enzyme committees that pyridoxal phosphate should be added, this is probably still done in only a minority of routine assays.
Addition of pyridoxal phosphate is an example of the effect of IFCC recommendations on those made at national level. It is possible that the IFCC provisional recommendations for alkaline phosphatase, with their choice of 2-amino-2-methyl-l-propanol (AMP) as the phosphate-accepting buffer and the addition of both magnesium and zinc at concentrations controlled by a chelating agent, will similarly influence routine methods, though this is not yet certain. Both the addition of pyridoxal phosphate to transaminase assays and supplementation of those for alkaline phosphatase with zinc are examples of changes which mtro-duce a sample-dependent element into enzyme activity measurements: the amount and proportion of potentially active apotransaminase has been shown to be highly variable between individual serum specimens, and it is possible that amounts and proportions of reversibly zinc-depleted alkaline phosphatase will be similarly sample-dependent. Thus, the relationships between the results reported by different method-groups in external surveys with samples which increasingly tend to contain only fully reactivated enzymes will fail to reflect the actual correspondence of results when patients' specimens are compared. Therefore, it is essential that any change in methodology which significantly alters numerical values of enzyme activity in a given specimen, such as the addition of pyridoxal phosphate to transaminase assays, should take place by national consensus rather than piecemeal, if the improvements in interlaboratory comparability already achieved, and demonstrated for example in the United Kingdom by the UKEQAS, are not to be lost. It is to be hoped that national societies will be ready to respond to the enquiries that the ECCLS subcommittee will undoubtedly make, by pointing out those features of proposed methods that would involve minor changes in practice and could, therefore, be readily implemented, those that would be more difficult to implement, and any that would be incompatible with present and future practice.
A challenge to standardised methodology more serious than that posed by the proliferation of recommendations is the development of analysers which do not employ conventional wet chemistry and which, therefore, cannot operate recommended methods without modification. These developments, together with the multiplicity of recommended methods, have redirected attention towards the concept of standardisation through enzyme calibration materials. The use of enzyme calibrators has been a part of the operation of certain automatic analysers for many years: however, the transfer of activity values defined by one method to a quite different type of assay through calibration materials is a comparatively new concept. Some authorities believe that, since the property being measured is catalytic activity under defined conditions, calibration of one assay method in terms of another can never be valid. However, even if this extreme view is set aside, the use of enzyme calibrators must overcome certain practical problems. The most important of these is the demonstration of commutability.
To be used to calibrate one assay method in terms of another, the enzyme calibrator must be commutable; i.e. it must display the same relationship between the two methods as the same enzyme in human serum. Moreover, there must be a high degree of probability that the same relationship will also hold for each successive serum sample. The relationship between enzyme activities measured by two methods will depend on a variety of factors, some relating to the methods themselves and some to the samples being analysed. Furthermore, the effects of some of these factors will be predictable and some unpredictable. These factors can be controlled by a careful selection of methods and potential calibrators, and by a growing understanding of the factors involved. Claims for commutability based on the use of selected methods and calibrators must then be submitted to rigorous experimental tests: only if these are passed can the use of enzyme calibrators be contemplated, and then only in the validated applications. The subcommittee on enzyme reference materials of ECCLS has provisionally proposed minimum requirements Enzyme activity measurements 3 for the experimental validation of commutability. These requirements have been tested experimentally on the recently-developed reference preparation of y-glutamyltransferase prepared for the Community Bureau of Reference of the European Economic Community. The results have shown an acceptable level of commutability between the IFCC method for this enzyme and certain established national methods.
It is unlikely that enzyme assays will ever become standardised exclusively through the universal adoption of a single set of recommended methods, or alternatively, through the universal use of a single hierarchy of primary and secondary reference materials. Defined methods and enzyme reference materials are complementary approaches to standardisation, with methods taking the primary place since a functional property, catalytic activity, is being measured. What is needed is a clear understanding of theoretical principles and practical aims, free from unjustifiably rigid adherence to the one or uncritical and. undemanding targets for the other.
